Fabrice Le Boeuf Center for Innovative Cancer Research Ottawa Hospital Research Institute Biography Publications Institution JoVE Articles Fabrice Le Boeuf has not added a biography. If you are Fabrice Le Boeuf and would like to personalize this page please email our Author Liaison for assistance. Publications Bacterial-mediated Knockdown of Tumor Resistance to an Oncolytic Virus Enhances Therapy Molecular Therapy : the Journal of the American Society of Gene Therapy. Jun, 2014 | Pubmed ID: 24569832 Smac Mimetics and Innate Immune Stimuli Synergize to Promote Tumor Death Nature Biotechnology. Feb, 2014 | Pubmed ID: 24463573 Model-based Rational Design of an Oncolytic Virus with Improved Therapeutic Potential Nature Communications. 2013 | Pubmed ID: 23764612 Leukemia Cell-rhabdovirus Vaccine: Personalized Immunotherapy for Acute Lymphoblastic Leukemia Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Jul, 2013 | Pubmed ID: 23714728 [Genetic, Immunological, and Pharmacological Strategies to Generate Improved Oncolytic Viruses] Médecine Sciences : M/S. Feb, 2013 | Pubmed ID: 23452603 Resistance to Two Heterologous Neurotropic Oncolytic Viruses, Semliki Forest Virus and Vaccinia Virus, in Experimental Glioma Journal of Virology. Feb, 2013 | Pubmed ID: 23221568 Oncolytic Vaccinia 바이러스 안전 하 고 효과적으로 Xeroderma Pigmentosum의 마우스 모델에서 피부 종양을 취급 International Journal of Cancer. Journal International Du Cancer. Feb, 2013 | Pubmed ID: 22733395 Harnessing Oncolytic Virus-mediated Antitumor Immunity in an Infected Cell Vaccine Molecular Therapy : the Journal of the American Society of Gene Therapy. Sep, 2012 | Pubmed ID: 22760544 전파, 정화, 그리고 Oncolytic Vesicular 구 염 바이러스 변종 생체 조건 테스트 Methods in Molecular Biology (Clifton, N.J.). 2012 | Pubmed ID: 21948474 Oncolytic Poxvirus JX-594에 선택적으로 복제 유전자 경로 암에 일반적으로 활성화에 힘입어 암 세포를 파괴 하 고 Molecular Therapy : the Journal of the American Society of Gene Therapy. Dec, 2011 | Pubmed ID: 22186794 자 궁 경부 암 세포 Vesicular 구 염 바이러스 유도 Oncolysis의 감도: 인간 유 두 종 바이러스 감염의 잠재적인 역할 International Journal of Cancer. Journal International Du Cancer. Dec, 2011 | Pubmed ID: 22173567 인 간에 있는 Multi-mechanistic 암 대상 Oncolytic Poxvirus의 정 맥 배달 Nature. Sep, 2011 | Pubmed ID: 21886163 Vaccinia 바이러스의 히스톤 Deacetylase 억제제와 Oncolysis을 기반 으로합니다 PloS One. 2010 | Pubmed ID: 21283510 높은 처리량 Pharmacoviral 접근 소설 Oncolytic 바이러스 Sensitizers 식별합니다 Molecular Therapy : the Journal of the American Society of Gene Therapy. Jun, 2010 | Pubmed ID: 20389287 시너지는 상호작용 Oncolytic 바이러스 종양 살인을 증대 시킵니다 Molecular Therapy : the Journal of the American Society of Gene Therapy. May, 2010 | Pubmed ID: 20234341 유나이티드 바이러스: 암에 대 한 Oncolytic 태그 팀! Cytokine & Growth Factor Reviews. Apr-Jun, 2010 | Pubmed ID: 20227326 강력한 Oncolytic 자연 Pathogenicity의 부재에서 Raccoonpox 바이러스의 활동 Molecular Therapy : the Journal of the American Society of Gene Therapy. May, 2010 | Pubmed ID: 20160706 항 혈관 신생 무장 Oncolytic Vaccinia 바이러스의 신장 세포 암 모델 Antitumor 효능을 향상 시킵니다 Journal of Virology. Jan, 2010 | Pubmed ID: 19906926 Targeting of Interferon-beta to Produce a Specific, Multi-mechanistic Oncolytic Vaccinia Virus PLoS Medicine. Dec, 2007 | Pubmed ID: 18162040 Src-mediated Phosphorylation of Hsp90 in Response to Vascular Endothelial Growth Factor (VEGF) is Required for VEGF Receptor-2 Signaling to Endothelial NO Synthase Molecular Biology of the Cell. Nov, 2007 | Pubmed ID: 17855507 Endothelial Cell Migration During Angiogenesis Circulation Research. Mar, 2007 | Pubmed ID: 17395884 Phosphorylation of Focal Adhesion Kinase (FAK) on Ser732 is Induced by Rho-dependent Kinase and is Essential for Proline-rich Tyrosine Kinase-2-mediated Phosphorylation of FAK on Tyr407 in Response to Vascular Endothelial Growth Factor Molecular Biology of the Cell. Aug, 2006 | Pubmed ID: 16760434 Regulation of Vascular Endothelial Growth Factor Receptor 2-mediated Phosphorylation of Focal Adhesion Kinase by Heat Shock Protein 90 and Src Kinase Activities The Journal of Biological Chemistry. Sep, 2004 | Pubmed ID: 15247219 루시 페라 제 발현 재조합 바이러스의 높은 처리량의 적정 Vanessa Garcia1,2, Ramya Krishnan1,2, Colin Davis1,2, Cory Batenchuk1,2, Fabrice Le Boeuf1,3, Hesham Abdelbary1,3, Jean-Simon Diallo1,2 1Center for Innovative Cancer Research, Ottawa Hospital Research Institute, 2Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, 3Faculty of Medicine, University of Ottawa Biology
루시 페라 제 발현 재조합 바이러스의 높은 처리량의 적정 Vanessa Garcia1,2, Ramya Krishnan1,2, Colin Davis1,2, Cory Batenchuk1,2, Fabrice Le Boeuf1,3, Hesham Abdelbary1,3, Jean-Simon Diallo1,2 1Center for Innovative Cancer Research, Ottawa Hospital Research Institute, 2Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, 3Faculty of Medicine, University of Ottawa Biology